Ipamorelin
Also known as: IPA
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) originally developed by Novo Nordisk and later advanced by Helsinn/Nycomed. It is a selective ghrelin receptor agonist / growth hormone secretagogue (GHRP). Its defining feature versus older GHRPs (GHRP-2, GHRP-6, hexarelin) is that in preclinical and early clinical studies it raised GH without meaningfully increasing ACTH, cortisol, or prolactin. It is not FDA-approved for any indication; a Phase 2 trial for postoperative ileus failed to meet its primary endpoint and clinical development was discontinued. In the wellness/grey market it is sold as a research chemical and used off-label for anti-aging and body-composition goals despite no clinically validated human dose for those uses.
Pricing for Ipamorelin
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
COAs for Ipamorelin
117 third-party tests across 24 vendors. Each card links to the full report.
For
Ipamorelin
by Ion Peptide· batch IP10-05042026
For
Ipamorelin
by Ion Peptide· batch IP5-05042026
For
Ipamorelin
by NG Peptide· batch IPA10-01
For
Ipamorelin
by Moglabs· batch IPA002
For
Ipamorelin
by Prime Peptides· batch 3162026IPA
For
Ipamorelin
by Crush Research· batch CRIPA-10-2604-1
For
Ipamorelin
by OROS Research· batch OR-LPIPA5-426-B4
For
Ipamorelin
by Blank Peptides· batch 665394
For
Ipamorelin
by Amino Club· batch IPA0001
For
Ipamorelin
by Crush Research· batch CR-IPA10-2603-1
For
Ipamorelin
by Crush Research· batch CR-IPA10-2603-1
For
Ipamorelin
by Verified Peptides· batch IPA05261110K
For
Ipamorelin
by Peptidology· batch 1671
For
Ipamorelin
by Peptide Supply Co.· batch IPA10030526
For
Ipamorelin
by Glacier Aminos· batch IPA10GA-02
For
Ipamorelin
by Simple Peptide· batch IPA10-02242026-J
For
Ipamorelin
by Nox Amino· batch NA-CP0226-01
For
Ipamorelin
by Glacier Aminos· batch IPA10GA-01
For
Ipamorelin
by Ascension Peptides· batch 06-01260229
For
Ipamorelin
by Licensed Peptides· batch IPAMOR-01
For
Ipamorelin
by Ion Peptide· batch IPA10-02022026
For
Ipamorelin
by Ion Peptide
For
Ipamorelin
by Simple Peptide· batch PA01287026-1
For
Ipamorelin
by BioLongevity Labs· batch 29-3-46035
17 citations indexed for Ipamorelin
Study · 2026
Growth Hormone-Releasing Peptides: Investigation of Their Secondary Structure, Thermal Stability, and Model Membrane Interactions
Growth hormone-releasing peptides (GHRPs) comprise a group of small synthetic peptides that can effectively influence growth hormone secretion both in humans and animals.
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
review · 2026
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes.
Study · 2026
Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance
Peptides are a rapidly expanding drug class with a parallel and largely unregulated gray market that sells preparations directly to consumers for self-administration.
review · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
Study · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.